Xcout Intel
Pan Cancer T competitors & alternatives
The 12 closest competitors and alternatives to Pan Cancer T among biotechnology companies — ranked by similarity to what Pan Cancer T actually does, not by market-cap band.
Subscribe to see Pan Cancer T’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Pan Cancer T
Pan Cancer T develops pioneering T-cell receptor (TCR-T) cell therapies designed to empower patients' immune systems to target and overcome solid tumors. The company utilizes proprietary gene engineering to enhance T-cell fitness and persistence against unique cancer-specific intracellular targets.
Pan Cancer T at a glance
Pan Cancer T is a biotechnology company headquartered in Netherlands. Xcout tracks 10 named people at Pan Cancer T, including Dr. Rachel Abbott (Chief Executive Officer).
Pan Cancer T leadership
- Dr. Rachel AbbottChief Executive Officer
- Dr. Tom HoldichChief Medical Officer
- Dr. John TchelingerianChairman
- Dr. Dora HammerlVP R&D, Co-Founder
- Dr. Reinout HesselinkVP Process Development
- Lars OttevangerVP, Finance
4 more named people on record for Pan Cancer T, with roles, board committees and tenure — see the full roster →
Top 12 Pan Cancer T competitors
Ranked by semantic similarity — how close each company is to Pan Cancer T by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Elicera Therapeutics is a clinical-stage immuno-oncology company that develops genetically engineered cell and gene therapies, including CAR T-cell therapies and oncolytic viruses, to treat various types of cancer. The company utilizes its proprietary iTANK technology platform to enhance the immune system's ability to target and attack solid tumors.
Similar biotechnology company
ImmPACT Bio is a biotechnology company developing next-generation cancer immunotherapies, including dual-targeted CAR T-cell therapies. Its programs are intended to serve patients with B-cell malignancies and potentially other cancers, including solid tumors.
Similar biotechnology company
OverT Bio, Inc. is a New York-based biotechnology company that pioneers next-generation cellular therapies and biologics at scale. The company focuses on developing effective and safe cellular treatments for solid tumors.
Biotech
CPTx is a genetic medicines company that develops in vivo CAR-T therapies for cancer treatment. The company utilizes a proprietary single-stranded DNA (ssDNA) platform combined with lipid nanoparticle delivery systems to create scalable, non-viral genetic therapies.
Similar biotechnology company
Tiankeya (also known as Beijing TCR Cure Biopharma Technology Co., Ltd.) is a clinical-stage biopharmaceutical company founded in 2016 and headquartered in China, with operations in China and the United States. The company focuses on the innovation, development, and clinical translation of engineered T cell and immune cell therapies to treat cancer and solid tumors.
Biotech
Zelluna is a Norwegian biotechnology company developing T-cell receptor (TCR)-based natural killer (NK) cell therapies for cancer, with a focus on treating solid tumors. Its products are intended for oncology patients, particularly those with cancers that are difficult to treat using existing immunotherapies.
Similar biotechnology company
OneChain Immunotherapeutics is a biotechnology company based in Barcelona focused on the development of CAR-T cell therapies and in vivo platforms for cancer immunotherapy.
Similar biotechnology company
KiraGen Bio is a Boston-based biotechnology company pioneering the development of AI-driven, multiplex gene-edited CAR-T cell therapies designed to target and block tumor suppression.
Biotech
T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel T cell receptor engineered T cell therapies to fight cancer. The company is involved in biotechnology research and has a presence in Berlin, Germany.
Similar biotechnology company
Notch Therapeutics Inc. is a private biotechnology company founded in 2018 and headquartered in Toronto, Ontario, Canada. The company specializes in the development of engineered T-cell therapies.
Similar biotechnology company
Century Therapeutics is an innovative biotechnology company headquartered in Philadelphia, Pennsylvania. Its mission is to develop allogeneic, iPSC-derived NK and T cell therapies that are designed to be more effective, tolerable, and accessible.
Similar biotechnology company
Innovative Cellular Therapeutics is a China-based biotechnology company focused on developing cellular immunotherapies, particularly CAR-T therapies for cancer. It serves patients with hematologic and potentially solid-tumor cancers through clinical development and commercialization of engineered cell therapies.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Pan Cancer T and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Pan Cancer Tand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →